Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells.

Abstract

Levamisole is a synthetic phenylimidazolthiazole that was first introduced in 1966 as an anti-helmintic agent. Current studies have been focused upon its effect on immune response and on cancer treatment. We examined the molecular mechanisms of levamisole in the activation and maturation of human monocyte-derived dendritic cells (DC) and human T cells… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.